Investors aiming for above-average returns often turn to the practice of stock picking. Skillful choices in individual stocks can be a catalyst for substantial wealth growth.
The closing price of Verve Therapeutics Inc (NASDAQ: VERV) was $5.55 for the day, up 0.18% from the previous closing price of $5.54. In other words, the price has increased by $0.18 from its previous closing price. On the day, 1.16 million shares were traded. VERV stock price reached its highest trading level at $5.61 during the session, while it also had its lowest trading level at $5.26.
Ratios:
Our analysis of VERV’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 12.65 and its Current Ratio is at 12.65. In the meantime, Its Debt-to-Equity ratio is 0.14 whereas as Long-Term Debt/Eq ratio is at 0.12.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, H.C. Wainwright on April 08, 2024, initiated with a Buy rating and assigned the stock a target price of $15.
On April 13, 2023, Canaccord Genuity started tracking the stock assigning a Buy rating and target price of $29.
On February 01, 2023, Cantor Fitzgerald started tracking the stock assigning a Neutral rating and target price of $21.Cantor Fitzgerald initiated its Neutral rating on February 01, 2023, with a $21 target price.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Dec 02 ’24 when Dorval Allison sold 555 shares for $5.64 per share. The transaction valued at 3,130 led to the insider holds 5,380 shares of the business.
Ashe Andrew D. bought 76,000 shares of VERV for $475,760 on May 14 ’24. The insider now owns 342,509 shares after completing the transaction at $6.26 per share. On Apr 02 ’24, another insider, Nickerson Joan, who serves as the Chief Administrative Officer of the company, sold 1,514 shares for $8.24 each. As a result, the insider received 12,475 and left with 8,659 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, VERV now has a Market Capitalization of 492816704 and an Enterprise Value of 38518512. For the stock, the TTM Price-to-Sale (P/S) ratio is 15.24 while its Price-to-Book (P/B) ratio in mrq is 1.00. Its current Enterprise Value per Revenue stands at 1.191 whereas that against EBITDA is -0.174.
Stock Price History:
The Beta on a monthly basis for VERV is 1.78, which has changed by -0.57826746 over the last 52 weeks, in comparison to a change of 0.086116076 over the same period for the S&P500. Over the past 52 weeks, VERV has reached a high of $14.26, while it has fallen to a 52-week low of $4.30. The 50-Day Moving Average of the stock is -19.50%, while the 200-Day Moving Average is calculated to be -7.26%.
Shares Statistics:
VERV traded an average of 1.44M shares per day over the past three months and 1157080 shares per day over the past ten days. A total of 88.76M shares are outstanding, with a floating share count of 66.18M. Insiders hold about 25.47% of the company’s shares, while institutions hold 69.88% stake in the company. Shares short for VERV as of 1740700800 were 14864938 with a Short Ratio of 10.31, compared to 1738281600 on 13253528. Therefore, it implies a Short% of Shares Outstanding of 14864938 and a Short% of Float of 19.81.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
